(E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)acrylonitrile

Catalog No. :
ACWFVT934
CAS No. :
1150310-15-8
Molecular Formula :
C15H15N3O5
Molecular Weight :
317.30

IUPAC Name:(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)acrylonitrile

(E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)acrylonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)acrylonitrile
IUPAC Name(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)acrylonitrile
Molecular FormulaC15H15N3O5
Molecular Weight317.30
SMILESN#C/C(C(N1CCCCC1)=O)=C\C2=CC([N+]([O-])=O)=C(O)C(O)=C2
InChI KeyNVHDZUJODMCISU-IZZDOVSWSA-N
Synonym(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile;Entacapone impurity H;Entacapone Impurity 24(Entacapone EP Impurity H);(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)prop-2-enenitrile;Entacapone Impurity 8(Entacapone EP Impurity H);(2E)-3-(3,4-Dihydroxy-5-nitrophenyl;1-Piperidinepropanenitrile, α-[(3,4-dihydroxy-5-nitrophenyl)methylene]-β-oxo-, (αE)-;-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-&beta
CAS No.1150310-15-8

Synthetic Route by SureRoute

1. ACWFVT934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTNS563 route compound structure diagram
    ACLTNS56315029-30-8 In Stock
  2. Plus
  3. ACGFNE823 route compound structure diagram
    ACGFNE823116313-85-0 In Stock
  4. Then
  5. ACWFVT934 route product structure diagram
    ACWFVT9341150310-15-8
Inquiry

2. ACWFVT934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWFVT934 route product structure diagram
    ACWFVT9341150310-15-8
Inquiry

Comments (0)